Bradley Evan Burnam - 07 Oct 2025 Form 3 Insider Report for Turn Therapeutics Inc. (TTRX)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Bradley Burnam
Issuer symbol: TTRX
Transactions as of: 07 Oct 2025
Net transactions value: $0
Form type: 3
Filing time: 07 Oct 2025, 19:08:47 UTC
SEC: View on sec.gov

Reporting Owners (2)

Name	Relationship	Address	Signature	Signature date	CIK
Burnam Bradley Evan	Chief Executive Officer, Director, 10%+ Owner	C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE	/s/ Bradley Burnam	07 Oct 2025	0002087366
BEB Holdings, LLC	10%+ Owner	C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE	/s/ Bradley Burnam, sole member of BEB Holdings, LLC	07 Oct 2025	0002087363

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TTRX	Common Stock						16,016,260	07 Oct 2025	By BEB Holdings, LLC	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of shares of common stock reported gives effect to the 2-for-1 forward stock split that took effect on September 30, 2025.
F2	Represents shares of common stock held by BEB Holdings, LLC. The reporting person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. Accordingly, all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person.

Remarks:

Exhibit 24 - Power of Attorney